Careers
Contact Us
Global
- Global
- Japan
- Taiwan

About Us
Alluminox®
Pipeline
- - - Pipeline
  - - Expanded Access Program
News
Careers
Contact Us
Global
- - - Global
  - - Japan
  - - Taiwan

Press Releases

All

December 18, 2025

Rakuten Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15th, 2026

November 10, 2025

Rakuten Medical Presents Poster at SITC 2025 Reporting Immune Activation in Operable HNSCC and cuSCC Treated with ASP-1929 Photoimmunotherapy Prior to Surgery

September 18, 2025

Rakuten Medical Announces Publication in Head & Neck of Phase 1b/2 Clinical Study of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab

July 28, 2025

Rakuten Medical Expands Patient Recruitment to Japan and Prepares for Expansion to Eastern Europe in Global Phase 3 Trial of ASP-1929 Photoimmunotherapy Combined with Pembrolizumab for 1L Recurrent Head and Neck Cancer

June 26, 2025

Rakuten Medical and Orient EuroPharma Sign Exclusive Licensing Agreement for Alluminox™ Platform-based Photoimmunotherapy in Taiwan, Malaysia, Singapore, and the Philippines

« Previous 1 2 3 4 … 17 Next »

Year Archive

2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Related Content

About Us

About Us
Letter from Our CEO
Leadership
Location

About

About
Letter from Our CEO
Leadership
Location

Pipeline

Pipeline
Expanded Access Program

Pipeline

Pipeline
Expanded Access Program

News

News
Press Releases
Rakuten Medical Stories
Press Kit

News

News
Press Releases
Rakuten Medical Stories
Press Kit

Contact

Privacy Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.

Cookie Settings Accept All Cookies

Privacy & Cookies Policy

Privacy Overview

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.
Do not sell my personal information

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

SAVE & ACCEPT

Press Releases

All

Rakuten Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15th, 2026

Rakuten Medical Presents Poster at SITC 2025 Reporting Immune Activation in Operable HNSCC and cuSCC Treated with ASP-1929 Photoimmunotherapy Prior to Surgery

Rakuten Medical Announces Publication in Head & Neck of Phase 1b/2 Clinical Study of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab

Rakuten Medical Expands Patient Recruitment to Japan and Prepares for Expansion to Eastern Europe in Global Phase 3 Trial of ASP-1929 Photoimmunotherapy Combined with Pembrolizumab for 1L Recurrent Head and Neck Cancer

Rakuten Medical and Orient EuroPharma Sign Exclusive Licensing Agreement for Alluminox™ Platform-based Photoimmunotherapy in Taiwan, Malaysia, Singapore, and the Philippines

Year Archive

Related Content

Rakuten Medical Stories

Press Kit

About Us

Alluminox®

Alluminox®

Pipeline

Partnering

Partnering

News

Careers

Contact

Careers

Contact